Benzinga
Benzinga
Benzinga
miércoles, septiembre 16

Anixa Biosciences Inc

ANIXNASDAQ
Trade with Public
Trade with Public
$2.65
-0.04-1.49%
Últ. Act.: Sep 16, 10:37 AM
Ganancias: Los beneficios de Q3 2026 se publicaron el mié sept 9th, después del cierre del mercado
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Anixa Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Anixa Biosciences (ANIX).

Price Target Range — 12 Quarters

Analyst Consensus — 5 Analysts

5Buy
Consensus RatingBuy# Analysts5Avg. Consensus PT$9Upside to Avg. PT+247.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →
DateFirmAnalystActionRating ChangePrice Target
Jun 30, 2026D. Boral CapitalJason KolbertAssumesBuy$10
Apr 8, 2026D. Boral CapitalJason KolbertMaintainedBuy$10
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $7 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved